Benzinga··Globe NewswireServier Acquires Day One Biopharmaceuticals for $2.5B to Bolster Rare Oncology Pipeline
Servier acquires Day One Biopharmaceuticals for $2.5B in cash, expanding rare pediatric oncology portfolio with closing expected Q2 2026.
DAWNacquisitionbiopharmaceutical